WJ+ Wharton's Jelly
A concentrated umbilical cord Wharton's Jelly product with live cells kept in the native Wharton's Jelly matrix. For non-IV procedures only.
Product illustration. Photos available on request. Actual packaging may differ.
A structural matrix made from umbilical cord Wharton's Jelly. It's mixed 1:1 with another biologic to hold it at the injection site.
Part of the biologics line. Compare all 11 products by type, format, and storageCommon in: Orthopedics & sports medicine · Pain management · Aesthetics
| Sizes | 1 mL · 2 mL |
|---|---|
| Mixing | 1:1 with companion biologic |
From Comprehensive Biosciences materials. Confirm current specs and IFU before use.
Biotechnology company founded in 2022 and led by Dr. Charles Sly and Dr. Roy Korth, with patented methods for isolating serum components and perinatal tissue. Its birth-tissue line comes from a manufacturer-owned, FDA-registered tissue bank: Wharton's Jelly, exosomes, Muse cell products, cord blood plasma extract, and Bio Scaffolding.
A concentrated umbilical cord Wharton's Jelly product with live cells kept in the native Wharton's Jelly matrix. For non-IV procedures only.
WJ+ with the live cells removed, keeping the growth factors, hyaluronic acid, exosomes, and ECM proteins. A cell-free option for non-IV procedures.